Regeneron Pharmaceuticals (REGN) Interest Coverage Ratio: History & Chart

Regeneron Pharmaceuticals, Inc.(REGN)

Biotechnology · Tarrytown, NY

$781.49-11.77 (-1.48%)

Delayed quote: Sep 11, 2026, 4:00 PM EDT

About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeutic portfolio includes EYLEA, an injection used to treat various ophthalmic conditions such as wet age-related macular degeneration, diabetic macular edema, myopic choroidal neovascularization, diabetic retinopathy, and macular edema resulting from retinal vein occlusion (both central and branch). Other significant offerings are Dupixent, an injectable solution for atopic dermatitis and asthma in both adults and pediatric patients; Libtayo, indicated for metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent, an injection prescribed for adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease; REGEN-COV for COVID-19; and Kevzara, a solution targeting rheumatoid arthritis in adult patients. Furthermore, Regeneron provides Inmazeb for infections caused by Zaire ebolavirus; ARCALYST, an injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and Muckle-Wells syndrome; and ZALTRAP, an intravenous infusion used in the treatment of metastatic colorectal cancer. In addition to its existing product lineup, the company is actively engaged in developing novel product candidates aimed at addressing unmet medical needs in areas such as ocular diseases, allergic and inflammatory conditions, cardiovascular and metabolic disorders, infectious diseases, rare diseases, cancer, pain management, and hematologic conditions. Regeneron maintains extensive collaboration and licensing agreements with a diverse range of partners, including Sanofi, Bayer, Teva Pharmaceutical Industries Ltd., Mitsubishi Tanabe Pharma Corporation, Alnylam Pharmaceuticals, Inc., Roche Pharmaceuticals, and Kiniksa Pharmaceuticals, Ltd. It also holds agreements with entities such as the U.S. Department of Health and Human Services, Zai Lab Limited, Intellia Therapeutics, Inc., the Biomedical Advanced Research Development Authority, and AstraZeneca PLC. The company was founded in 1988 and its corporate headquarters are situated in Tarrytown, New York.

Tarrytown, NY

15,410 employees

www.regeneron.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Leonard S. Schleifer

View full financials

REGN Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

81.69x

INTEREST COVERAGE RATIO AVG TTM

120.83x

INTEREST COVERAGE RATIO AVG 3Y

70.85x

INTEREST COVERAGE RATIO AVG 5Y

77.00x

INTEREST COVERAGE RATIO AVG 10Y

80.97x

INTEREST COVERAGE RATIO AVG 15Y

61.84x

INTEREST COVERAGE RATIO AVG 20Y

52.15x

CURRENT VS TTM AVG

-32.39%

CURRENT VS 3Y AVG

+15.29%

CURRENT VS 5Y AVG

+6.09%

CURRENT VS 10Y AVG

+0.89%

CURRENT VS 15Y AVG

+32.09%

CURRENT VS 20Y AVG

+56.65%

SECTOR MEDIAN · HEALTHCARE

6.88x

median of 82 covered companies

CURRENT VS SECTOR MEDIAN

+1086.49%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Regeneron Pharmaceuticals, Inc. (REGN)	$80.51B	81.69x	120.83x	70.85x	77.00x
Cigna Corporation (CI)vs ›	$74.19B	6.61x	6.58x	6.49x	6.37x
Elevance Health Inc. (ELV)vs ›	$90.81B	5.79x	6.64x	7.93x	8.79x
HCA Healthcare, Inc. (HCA)vs ›	$92.43B	5.32x	5.22x	5.16x	5.27x
GSK plc (GSK)vs ›	$96.43B	12.14x	9.13x	8.62x	7.79x
Boston Scientific Corporation (BSX)vs ›	$63.88B	11.38x	9.10x	7.54x	6.16x
Cencora, Inc. (COR)vs ›	$62.57B	8.69x	10.46x	10.41x	11.51x
Sanofi (SNY)vs ›	$102.70B	15.33x	13.49x	16.74x	20.21x
McKesson Corporation (MCK)vs ›	$103.21B	26.13x	21.60x	19.33x	18.13x
Moderna, Inc. (MRNA)vs ›	$57.13B	-307.40x	531.75x	531.75x	531.75x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Regeneron Pharmaceuticals, Inc. (REGN)

$80.51B

81.69x

120.83x

70.85x

77.00x

Cigna Corporation (CI)vs ›

$74.19B

6.61x

6.58x

6.49x

6.37x

Elevance Health Inc. (ELV)vs ›

$90.81B

5.79x

6.64x

7.93x

8.79x

HCA Healthcare, Inc. (HCA)vs ›

$92.43B

5.32x

5.22x

5.16x

5.27x

GSK plc (GSK)vs ›

$96.43B

12.14x

9.13x

8.62x

7.79x

Boston Scientific Corporation (BSX)vs ›

$63.88B

11.38x

9.10x

7.54x

6.16x

Cencora, Inc. (COR)vs ›

$62.57B

8.69x

10.46x

10.41x

11.51x

Sanofi (SNY)vs ›

$102.70B

15.33x

13.49x

16.74x

20.21x

McKesson Corporation (MCK)vs ›

$103.21B

26.13x

21.60x

19.33x

18.13x

Moderna, Inc. (MRNA)vs ›

$57.13B

-307.40x

531.75x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Regeneron Pharmaceuticals, Inc. (REGN)?

The interest coverage ratio for REGN stock is 81.69x.

Is Regeneron Pharmaceuticals, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 81.69x is in line with its 5-year average of 77.00x, near the low end of its 5-year range (46.67x–299.86x).

What is the TTM average interest coverage ratio for Regeneron Pharmaceuticals, Inc. (REGN)?

The TTM average interest coverage ratio for REGN stock is 120.83x.

What is the 3Y average interest coverage ratio for Regeneron Pharmaceuticals, Inc. (REGN)?

The 3Y average interest coverage ratio for REGN stock is 70.85x.

What is the 5Y average interest coverage ratio for Regeneron Pharmaceuticals, Inc. (REGN)?

The 5Y average interest coverage ratio for REGN stock is 77.00x.

What is the 10Y average interest coverage ratio for Regeneron Pharmaceuticals, Inc. (REGN)?

The 10Y average interest coverage ratio for REGN stock is 80.97x.

What is the 15Y average interest coverage ratio for Regeneron Pharmaceuticals, Inc. (REGN)?

The 15Y average interest coverage ratio for REGN stock is 61.84x.

What is the 20Y average interest coverage ratio for Regeneron Pharmaceuticals, Inc. (REGN)?

The 20Y average interest coverage ratio for REGN stock is 52.15x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	129.14x
2026-03-31	49.84x
2025-12-31	72.12x
2025-09-30	53.20x
2025-06-30	299.86x
2025-03-31	68.01x
2024-12-31	94.30x
2024-09-30	85.47x
2024-06-30	72.27x
2024-03-31	46.67x
2023-12-31	57.42x
2023-09-30	68.03x
2023-06-30	53.78x
2023-03-31	55.71x
2022-12-31	75.60x
2022-09-30	79.98x
2022-06-30	99.76x
2022-03-31	94.60x
2021-12-31	187.21x
2021-09-30	130.08x
2021-06-30	232.44x
2021-03-31	76.21x
2020-12-31	78.85x
2020-09-30	40.04x
2020-06-30	67.67x
2020-03-31	114.77x
2019-12-31	100.85x
2019-09-30	94.68x
2019-06-30	39.45x
2019-03-31	62.34x
2018-12-31	97.71x
2018-09-30	83.66x
2018-06-30	89.94x
2018-03-31	88.09x
2017-12-31	89.28x
2017-09-30	90.57x
2017-06-30	101.89x
2017-03-31	57.40x
2016-12-31	102.24x
2016-09-30	731.46x
2016-06-30	134.21x
2016-03-31	234.22x
2015-12-31	64.03x
2015-09-30	228.82x
2015-06-30	125.49x
2015-03-31	45.96x
2014-12-31	38.96x
2014-09-30	20.41x
2014-06-30	22.41x
2014-03-31	16.50x
2013-12-31	18.19x
2013-09-30	20.18x
2013-06-30	13.91x
2013-03-31	13.11x
2012-12-31	12.67x
2012-09-30	17.73x
2012-06-30	8.03x
2012-03-31	1.99x
2011-12-31	-4.80x
2011-09-30	-14.39x
2011-06-30	-14.90x
2011-03-31	-11.02x
2010-12-31	4.22x
2010-09-30	-14.37x
2010-06-30	-10.13x
2010-03-31	-13.75x
2009-12-31	-22.44x
2009-09-30	-2.22x
2008-12-31	-2.83x
2008-06-30	-7.34x
2008-03-31	-5.28x
2006-09-30	-9.38x

DATE

INTEREST COVERAGE RATIO

2026-06-30

129.14x

2026-03-31

49.84x

2025-12-31

72.12x

2025-09-30

53.20x

2025-06-30

299.86x

2025-03-31

68.01x

2024-12-31

94.30x

2024-09-30

85.47x

2024-06-30

72.27x

2024-03-31

46.67x

2023-12-31

57.42x

2023-09-30

68.03x

2023-06-30

53.78x

2023-03-31

55.71x

2022-12-31

75.60x

2022-09-30

79.98x

2022-06-30

99.76x

2022-03-31

94.60x

2021-12-31

187.21x

2021-09-30

130.08x

2021-06-30

232.44x

2021-03-31

76.21x

2020-12-31

78.85x

2020-09-30

40.04x

2020-06-30

67.67x

2020-03-31

114.77x

2019-12-31

100.85x

2019-09-30

94.68x

2019-06-30

39.45x

2019-03-31

62.34x

2018-12-31

97.71x

2018-09-30

83.66x

2018-06-30

89.94x

2018-03-31

88.09x

2017-12-31

89.28x

2017-09-30

90.57x

2017-06-30

101.89x

2017-03-31

57.40x

2016-12-31

102.24x

2016-09-30

731.46x

2016-06-30

134.21x

2016-03-31

234.22x

2015-12-31

64.03x

2015-09-30

228.82x

2015-06-30

125.49x

2015-03-31

45.96x

2014-12-31

38.96x

2014-09-30

20.41x

2014-06-30

22.41x

2014-03-31

16.50x

2013-12-31

18.19x

2013-09-30

20.18x

2013-06-30

13.91x

2013-03-31

13.11x

2012-12-31

12.67x

2012-09-30

17.73x

2012-06-30

8.03x

2012-03-31

1.99x

2011-12-31

-4.80x

2011-09-30

-14.39x

2011-06-30

-14.90x

2011-03-31

-11.02x

2010-12-31

4.22x

2010-09-30

-14.37x

2010-06-30

-10.13x

2010-03-31

-13.75x

2009-12-31

-22.44x

2009-09-30

-2.22x

2008-12-31

-2.83x

2008-06-30

-7.34x

2008-03-31

-5.28x

2006-09-30

-9.38x

Interest Coverage Ratio: 81.69x

REGN Interest Coverage Ratio

REGN Average Interest Coverage Ratio Chart

REGN Current vs Average Interest Coverage Ratio Chart

REGN Interest Coverage Ratio Metrics

REGN Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

REGN Interest Coverage Ratio History

Related Metrics